All stock lists
Endava plc (New York Stock Exchange:DAVA)
GB · Delayed Price · Currency is USD
Technology · Information Technology Services
1.65+0.07 (+4.43%)
Market cap
$92.7M
Insider Score
Health Score
Analyst consensus
Listed since
Jul 27, 2018
Website
Insider Score
––Not scored
DAVA Insider Score
Insiders here have filed 4 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
DAVA analyst forecast
DAVA analyst consensus
Hold3 ratings
Buy 0 Hold 2 Sell 1
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
DAVA 12-month price target
No published price targets in the last 12 months.
DAVA ratings mix, last 12 months
Buy Hold Sell
Best analysts covering DAVA
- Needham0%success rate · -53.8% avg return · 19 calls
- Guggenheim0%success rate · -71.9% avg return · 8 calls
- TD Cowen0%success rate · -53.0% avg return · 5 calls
- JP Morgan0%success rate · -50.5% avg return · 4 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
DAVA analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | TD Cowen | Hold | — | — | Reiterated | 2026-09-22 |
| — | William Blair | Underperform | — | — | Downgraded | 2026-09-22 |
| — | Deutsche Bank | Hold | — | — | Reiterated | 2026-09-22 |
| — | TD Cowen | Hold | — | — | Reiterated | 2026-07-09 |
| — | Guggenheim | Neutral | — | — | Downgraded | 2026-05-27 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2026-05-22 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-05-22 |
| — | TD Cowen | Hold | — | — | Reiterated | 2026-05-22 |
| — | Needham | Buy | — | — | Reiterated | 2026-05-21 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-04-06 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2026-02-20 |
| — | Needham | Buy | — | — | Reiterated | 2026-02-19 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-02-13 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-11-13 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-11-12 |
| — | Needham | Buy | — | — | Reiterated | 2025-11-12 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-11-12 |
| — | William Blair | Market Perform | — | — | Downgraded | 2025-11-11 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-09-05 |
| — | Needham | Buy | — | — | Reiterated | 2025-09-05 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-09-05 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-08-28 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-08-20 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-06-10 |
| — | Needham | Buy | — | — | Reiterated | 2025-06-10 |
| — | Susquehanna | Positive | — | — | Reiterated | 2025-05-20 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2025-05-19 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-05-15 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-05-15 |
| — | Needham | Buy | — | — | Reiterated | 2025-05-15 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-05-13 |
| — | Needham | Buy | — | — | Reiterated | 2025-02-21 |
| — | Susquehanna | Positive | — | — | Reiterated | 2025-02-21 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-01-31 |
| — | Needham | Buy | — | — | Reiterated | 2025-01-10 |
| — | Needham | Buy | — | — | Reiterated | 2024-11-14 |
| — | TD Cowen | Buy | — | — | Reiterated | 2024-11-13 |
| — | Guggenheim | Buy | — | — | Reiterated | 2024-11-06 |
| — | Citigroup | Neutral | — | — | Reiterated | 2024-10-28 |
| — | Susquehanna | Positive | — | — | Reiterated | 2024-09-20 |
| — | Needham | Buy | — | — | Reiterated | 2024-09-20 |
| — | Guggenheim | Buy | — | — | Reiterated | 2024-09-16 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2024-09-06 |
| — | TD Cowen | Buy | — | — | Reiterated | 2024-05-24 |
| — | Needham | Buy | — | — | Reiterated | 2024-05-24 |
| — | Guggenheim | Buy | — | — | Reiterated | 2024-05-24 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2024-05-24 |
| — | Wedbush | Outperform | — | — | Reiterated | 2024-05-23 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2024-05-02 |
| — | HSBC | Buy | — | — | Upgraded | 2024-05-01 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2024-04-22 |
| — | Citigroup | Neutral | — | — | Reiterated | 2024-04-22 |
| — | JP Morgan | Overweight | — | — | Upgraded | 2024-03-19 |
| — | Susquehanna | Positive | — | — | Reiterated | 2024-03-12 |
| — | Needham | Buy | — | — | Reiterated | 2024-03-12 |
| — | Citigroup | Neutral | — | — | Downgraded | 2024-03-01 |
| — | Needham | Buy | — | — | Reiterated | 2024-03-01 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2024-03-01 |
| — | TD Cowen | Outperform | — | — | Reiterated | 2024-03-01 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2024-02-14 |
DAVA earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2025-09-04 | 0.32 | 0.33 | $256.4M | $256.4M |
| 2025-11-11 | 0.25 | 0.20 | $244.7M | $239.5M |
| 2026-02-19 | 0.21 | 0.22 | $186.4M | $248.0M |
| 2026-05-21 | 0.27 | 0.07 | $242.8M | $236.0M |
| 2026-11-10Upcoming | 0.16 | — | $241.9M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.